HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

mannopyranosyl- (1- 4)- 2- acetamido- 2- deoxyglucopyranosyl- (1- 4)- 2- acetamido- 2- deoxyglucopyranose

Also Known As:

Man-1-4-GlcNAc-1-4-GlcNAc; Man1GlcNAc2; Manbeta1-4GlcNAcbeta1-4GlcNAc

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Oligosaccharides: 3566
    - Trisaccharides: 123
      - mannopyranosyl-(1-4)-2-acetamido-2-deoxyglucopyranosyl-(1-4)-2-acetamido-2-deoxyglucopyranose: 1

Experts

1.	Braulke, Thomas: 1 article (06/2003)
2.	Grzmil, Michal: 1 article (06/2003)
3.	Hasilik, Martin: 1 article (06/2003)
4.	Kohlschütter, Alfried: 1 article (06/2003)
5.	Körner, Christian: 1 article (06/2003)
6.	Lehle, Ludwig: 1 article (06/2003)
7.	Peng, Jianhe: 1 article (06/2003)
8.	Schwarz, Markus: 1 article (06/2003)
9.	Thiel, Christian: 1 article (06/2003)
10.	von Figura, Kurt: 1 article (06/2003)

Related Diseases

1.	Congenital Disorders of Glycosylation 06/20/2003 - "Deficiency of GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2), is the cause of a new type of congenital disorders of glycosylation (CDG) designated CDG-Ii. The patient presented normal at birth but developed in the 1st year of life a multisystemic disorder with mental retardation, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities. "
2.	Seizures (Absence Seizure) 06/20/2003 - "Deficiency of GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2), is the cause of a new type of congenital disorders of glycosylation (CDG) designated CDG-Ii. The patient presented normal at birth but developed in the 1st year of life a multisystemic disorder with mental retardation, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities. "
3.	Intellectual Disability (Idiocy) 06/20/2003 - "Deficiency of GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2), is the cause of a new type of congenital disorders of glycosylation (CDG) designated CDG-Ii. The patient presented normal at birth but developed in the 1st year of life a multisystemic disorder with mental retardation, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities. "
4.	Hepatomegaly 06/20/2003 - "Deficiency of GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2), is the cause of a new type of congenital disorders of glycosylation (CDG) designated CDG-Ii. The patient presented normal at birth but developed in the 1st year of life a multisystemic disorder with mental retardation, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities. "
5.	Coloboma (Colobomas) 06/20/2003 - "Deficiency of GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (hALG2), is the cause of a new type of congenital disorders of glycosylation (CDG) designated CDG-Ii. The patient presented normal at birth but developed in the 1st year of life a multisystemic disorder with mental retardation, seizures, coloboma of the iris, hypomyelination, hepatomegaly, and coagulation abnormalities. "

Related Drugs and Biologics

1.	Mannosyltransferases
2.	Guanosine Diphosphate (GDP)
3.	Dolichols